Literature DB >> 18565904

Osteosarcoma: the same old drugs or more?

Stefan S Bielack, Neyssa Marina, Stefano Ferrari, Lee J Helman, Sigbjørn Smeland, Jeremy S Whelan, Gregory H Reaman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18565904     DOI： 10.1200/JCO.2008.17.1108

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  27 in total

1.  MicroRNA-34a promotes cell cycle arrest and apoptosis and suppresses cell adhesion by targeting DUSP1 in osteosarcoma.

Authors:  Liu Gang; Li Qun; Wei-Dong Liu; Yong-Sheng Li; Yao-Zeng Xu; Dong-Tang Yuan
Journal:  Am J Transl Res       Date:  2017-12-15       Impact factor: 4.060

Review 2.  Aerosol therapy for the treatment of osteosarcoma lung metastases: targeting the Fas/FasL pathway and rationale for the use of gemcitabine.

Authors:  Nancy Gordon; Eugenie S Kleinerman
Journal:  J Aerosol Med Pulm Drug Deliv       Date:  2010-08       Impact factor: 2.849

3.  Long non-coding RNA small nucleolar RNA host gene 12 (SNHG12) promotes cell proliferation and migration by upregulating angiomotin gene expression in human osteosarcoma cells.

Authors:  Wendong Ruan; Pei Wang; Shiqing Feng; Yuan Xue; Yulin Li
Journal:  Tumour Biol       Date:  2015-10-20

Review 4.  Mifamurtide: a review of its use in the treatment of osteosarcoma.

Authors:  James E Frampton
Journal:  Paediatr Drugs       Date:  2010-06       Impact factor: 3.022

5.  MEG3 inhibits proliferation and invasion and promotes apoptosis of human osteosarcoma cells.

Authors:  Yao Shi; Chen Lv; Li Shi; Guanjun Tu
Journal:  Oncol Lett       Date:  2017-11-21       Impact factor: 2.967

6.  MicroRNA-199a-3p is downregulated in human osteosarcoma and regulates cell proliferation and migration.

Authors:  Zhenfeng Duan; Edwin Choy; David Harmon; Xianzhe Liu; Michiro Susa; Henry Mankin; Francis Hornicek
Journal:  Mol Cancer Ther       Date:  2011-06-10       Impact factor: 6.261

Review 7.  Mifamurtide for the treatment of nonmetastatic osteosarcoma.

Authors:  Kosei Ando; Kanji Mori; Nedège Corradini; Françoise Redini; Dominique Heymann
Journal:  Expert Opin Pharmacother       Date:  2011-02       Impact factor: 3.889

8.  Enhanced anti-tumor activity and safety profile of targeted nano-scaled HPMA copolymer-alendronate-TNP-470 conjugate in the treatment of bone malignances.

Authors:  Ehud Segal; Huaizhong Pan; Liat Benayoun; Pavla Kopečková; Yuval Shaked; Jindřich Kopeček; Ronit Satchi-Fainaro
Journal:  Biomaterials       Date:  2011-03-22       Impact factor: 12.479

9.  Review of mifamurtide in the treatment of patients with osteosarcoma.

Authors:  Leo Kager; Ulrike Pötschger; Stefan Bielack
Journal:  Ther Clin Risk Manag       Date:  2010-06-24       Impact factor: 2.423

10.  MicroRNA-21 promotes proliferation, invasion and suppresses apoptosis in human osteosarcoma line MG63 through PTEN/Akt pathway.

Authors:  Chen Lv; Yuehan Hao; Guanjun Tu
Journal:  Tumour Biol       Date:  2016-01-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.